OBJECTIVE: To evaluate triptan use patterns in a large Israeli HMO district. BACKGROUND: Triptans, 5HT(1B/1D) agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack. METHOD: We retrospectively reviewed the computerized prescription filling data of 1498 patients who filled a first triptan prescription between July 2003 and June 2004. RESULTS: During a 1-year follow-up period, 841 patients (56.1%) purchased triptans only once. Single-time users were significantly more prevalent among men and in patients younger than 30 or older than 70 years. CONCLUSIONS: It seems that many migraine patients choose not to use triptans after their first experience with the drug.
OBJECTIVE: To evaluate triptan use patterns in a large Israeli HMO district. BACKGROUND:Triptans, 5HT(1B/1D) agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack. METHOD: We retrospectively reviewed the computerized prescription filling data of 1498 patients who filled a first triptan prescription between July 2003 and June 2004. RESULTS: During a 1-year follow-up period, 841 patients (56.1%) purchased triptans only once. Single-time users were significantly more prevalent among men and in patients younger than 30 or older than 70 years. CONCLUSIONS: It seems that many migrainepatients choose not to use triptans after their first experience with the drug.
Authors: Rachelle R Ramsey; Jamie L Ryan; Andrew D Hershey; Scott W Powers; Brandon S Aylward; Kevin A Hommel Journal: Headache Date: 2014-04-17 Impact factor: 5.887
Authors: Richard B Lipton; Steven C Marcus; Anand R Shewale; David W Dodick; Hema N Viswanathan; Jalpa A Doshi Journal: Cephalalgia Date: 2020-03-05 Impact factor: 6.292